The global Cell Penetrating Peptide Market is poised for exceptional growth, as it is projected to surge from US$ 2.16 billion in 2024 to an impressive US$ 8.12 billion by 2033, e ...

BrisSynBio has two CEM Liberty Blue automated, microwave-assisted peptide synthesisers. These support Fmoc peptide synthesis of sequences from two to about fifty residues at a scale from one to about ...

After a roller coaster ride of successes and failures, new discovery technologies and advances in manufacturing promise a brighter future for peptides in human therapy. Some 40 years after Nobel ...

Protein Synthesis: Amino Acids, mRNA, Ribosomes & Peptide Bonds Explained Posted: March 9, 2025 | Last updated: March 9, 2025 This film creatively illustrates the process of protein synthesis ...

increasing peptide synthesis capability, and a requirement for new tools that facilitate access to biosuperior peptide pharmaceuticals with improved efficacy and pharmacodynamics. Zentraxa uses the ...

A team of undergraduate researchers has developed an innovative way to produce essential medications more affordably and ...

Background Mechanical stress on the heart is commonly considered the sole stimulus explaining the synthesis and release of ...

HLB Group acquires ANYGEN to boost GLP-1 obesity treatment development HLB Group enhances peptide capabilities through ANYGEN ...

In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract manufacturer Senn Chemicals. The deal, once closed, will immediately ...

In recognition of her contributions to flow-based peptide synthesis, particularly of post-translationally modified peptides and proteins, which enables and accelerates their systematic investigation.

Shilpa Medicare has launched its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers as well as peptides – with oncology a ...